Whole genome and exome sequencing associated six novel loci with serum B12 (CD320, TCN2, ABCD4, MMAA, MMACHC) or folate levels (FOLR3) with cardiovascular diseases, cancers, and neurodegenerative disorders. This evidence concerns the gene CD320 and cancer.